Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.
The researchers say the technology could eventually support more personalised care, allowing treatments to be better matched ...
Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...
Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...
On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA ...
Objective Patients with atrial fibrillation (AF) frequently have multiple comorbidities that increase the risk of hospitalisation and contribute to higher mortality. However, studies examining the ...
US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...
Hackensack Meridian JFK’s chief of cardiology explains how alcohol, salty foods, and holiday excess can lead to dangerous ...
New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...
Dr. Sowmya Lakshminarayanan, or “Dr. Lak,” a neurologist and stroke expert at Novant Health, says that holiday stress, ...
Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in ...
Because only about 90 minutes passed between your mother’s initial dose of the anticoagulant and the stroke, it is more likely the cause was a preexisting condition rather than an immediate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback